Trillium Therapeutics (TR) News Today Add Compare Share Share Headlines Stock Analysis All Sources Trusted Sources MarketBeat.com Benzinga Bloomberg GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha The Street TipRanks The Wall Street Journal Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 August 2022 July 2022 June 2022 May 2022 April 2022 March 2022 February 2022 January 2022 December 2021 Time Period Biomea Announces Formation of Global Scientific Advisory Board with 22 World-Renowned Diabetes ExpertsOctober 1, 2024 | markets.businessinsider.comKabete National Polytechnic Ranked Best TTI in New Timely Kenya SurveyMay 28, 2024 | msn.comPension plans still AWOL as Canadian life-sciences venture capital firms re-up for latest fundsMay 28, 2024 | theglobeandmail.comNimbus Therapeutics Appoints Anita Scheuber, M.D., Ph.D., as Senior Vice President, Therapeutic Area Head, OncologyMay 7, 2024 | finance.yahoo.comRatio Therapeutics Announces the Appointment of Marc Becker as Chief Financial Officer and Chief Operating OfficerMay 6, 2024 | finance.yahoo.comSezary Syndrome Pipeline Insights 2024, Featuring Major Players 4SC, Seagen, Merck Sharp & Dohme, Innate Pharma, Trillium Therapeutics and Secura BioApril 15, 2024 | finance.yahoo.comUpstream Bio Announces Appointment of Rand Sutherland as CEO and Additions to Leadership TeamApril 2, 2024 | finance.yahoo.comRatio Announces Expansion of Manufacturing Agreement with PharmaLogic for FAP-Targeted RadiopharmaceuticalsMarch 12, 2024 | finance.yahoo.comRatio Therapeutics raises $50M for tumor-targeting radiopharmaceuticalsJanuary 17, 2024 | bizjournals.comTvardi Therapeutics Announces First Patients Dosed in its Phase 2 Liver Cancer Trial Using TTI-101, a Novel STAT3 InhibitorJune 22, 2023 | finance.yahoo.comPD-1 Non-Small Cell Lung Cancer Clinical Trials Pipeline Analysis: 20+ Companies are Working to Improve the Treatment Space | DelveInsightJune 20, 2023 | benzinga.comRatio Therapeutics Announces Opening of New Research and Development FacilityMay 9, 2023 | finance.yahoo.comTrillium Engineering Announces Its Latest Innovation in Cameras Utilizing AI Technology - HD80-AIMApril 25, 2023 | finance.yahoo.comWho's Who At The Benzinga Psychedelics Capital Conference? Check Out These CEOs & Meet Them In PersonMarch 10, 2023 | msn.comViridian Therapeutics, Inc: Viridian Appoints Scott Myers as President and Chief Executive OfficerFebruary 6, 2023 | finanznachrichten.deTaylor Trillium building into Division 4 state power, behind coach Terrell GeorgeJanuary 28, 2023 | detroitnews.comLeiomyosarcoma Drug Pipeline Research Report 2022: Comprehensive Insights on 18+ Companies and 18+ Pipeline DrugsDecember 19, 2022 | benzinga.comRatio Therapeutics Appoints Reed Malleck as Chief Financial OfficerDecember 6, 2022 | finance.yahoo.comPfizer: Q3 Earnings Review - Planning For Life After COVIDNovember 3, 2022 | seekingalpha.comCash-rich Pfizer snaps up Global Blood Therapeutics for $5.4 billionAugust 8, 2022 | msn.comPfizer: Management's M&A Activity Is Winning Me OverMay 22, 2022 | seekingalpha.comThiogenesis Therapeutics, Corp.: Thiogenesis Announces Positive Results from Phase 1 Dose-Escalation Study of its Lead Compound TTI-0102May 18, 2022 | finanznachrichten.deThiogenesis Announces Positive Results from Phase 1 Dose-Escalation Study of its Lead Compound TTI-0102May 18, 2022 | stockhouse.com3 Dirt-Cheap Stocks You Can Buy Right NowMay 14, 2022 | msn.comPfizer Buys Biohaven for $11.6BMay 10, 2022 | baystreet.caNeonMind to Open its Inaugural Specialty Mental Health Clinic in Mississauga, OntarioFebruary 17, 2022 | morningstar.com$51,300 OTF Grant helped breast cancer patients in Ontario access educational resources during the pandemicJanuary 25, 2022 | yahoo.comTCR² Therapeutics Announces Experienced Biotech Executive Rosemary Harrison as Chief Business and Strategy OfficerJanuary 12, 2022 | finance.yahoo.comSensorion appoints pharmaceutical industry veteran Scott D. Myers as Chairman of the Board and Independent DirectorDecember 20, 2021 | apnews.comPfizer's $2.3B Trillium Deal Closes Without FTC ChallengeNovember 17, 2021 | law360.comWhy Pfizer Rose While the Market Sank on WednesdayNovember 17, 2021 | nasdaq.comQVT Financial LP Buys S&P 500 ETF TRUST ETF, Trillium Therapeutics Inc, Nelnet Inc, Sells ...November 17, 2021 | gurufocus.comPfizer Completes Acquisition of Trillium TherapeuticsNovember 17, 2021 | finance.yahoo.comPfizer Agrees $2.26 Billion Takeover of Cancer Specialists Trillium TherapeuticsAugust 23, 2021 | msn.comPfizer acquires Trillium Therapeutics at a 200% premiumAugust 23, 2021 | bizjournals.comBRIEF-Pfizer To Acquire Trillium Therapeutics Inc.August 23, 2021 | msn.comPremarket Movers Monday - Pfizer, Trillium, Uber and General MotorsAugust 23, 2021 | msn.comPromising Treatment for Cutaneous T-cell Lymphoma Enters Clinical TrialsAugust 3, 2021 | ca.finance.yahoo.comThis Biotech Stock Is Too Cheap to IgnoreJuly 29, 2021 | nasdaq.comStocks Flat to Begin WeekJuly 26, 2021 | baystreet.caStocks Stable by NoonJuly 26, 2021 | baystreet.ca Get Trillium Therapeutics News Delivered to You Automatically Sign up to receive the latest news and ratings for TR and its competitors with MarketBeat's FREE daily newsletter. Email Address My #1 Pre IPO Trade for 2025 – NAME and TICKER (Ad)One tiny company... Could quickly become "the next SpaceX." It plans to go public on the NASDAQ. And today you can buy Pre-IPO shares for less than $4.00. Get urgent details inside this free report... The Next SpaceX Pre-IPO TR Media Mentions By Week TR Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. TR News Sentiment▼0.000.69▲Average Manufacturing News Sentiment TR News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. TR Articles This Week▼00▲TR Articles Average Week Get Trillium Therapeutics News Delivered to You Automatically Sign up to receive the latest news and ratings for TR and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies K News KEL News BU News DAR News Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (TSE:TR) was last updated on 11/21/2024 by MarketBeat.com Staff From Our PartnersThe Crypto That’s Making Wall Street SweatThe Crypto Wall Street Is Desperate to Hide It's happening now, right under everyone's radar. Big tech gian...Crypto 101 Media | SponsoredMissed Nvidia? Watch this ASAPThis little-known project that Bill Gates has been quietly working on that’s about to unleash an AI breakthrou...Brownstone Research | SponsoredMusk’s new company could top a trillion?The investment legend who predicted the rise of Bitcoin, Facebook and streaming services like Netflix… Just...Paradigm Press | Sponsored24/7 Automated Profits in CryptoWhat if you could make consistent daily profits in crypto with minimal effort? Beyond trading lies a vast w...Crypto Swap Profits | SponsoredCrypto’s next big bull run?Juan Villaverde may be America’s top crypto expert. And he says something big is coming for crypto – on Nov...Weiss Ratings | Sponsored“This Changes Everything” - Trump Hands Millions Massive IRS GiftNow it's your time to return the favor by taking advantage of this tax "revenge loophole." Because even as ...Colonial Metals | SponsoredTim Sykes’ Urgent Trade Alert: “Make this move now”WARNING: 80 Wall Street banks are gearing up for MASSIVE D.C. shock This $2 trillion D.C. shock is NOT abou...Timothy Sykes | SponsoredUnveiled: NVIDIA’s "Secret Royalty" ProgramDid you know that there's an investment that will give you the opportunity to collect "royalties" every time N...Behind the Markets | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Trillium Therapeutics Inc Please log in to your account or sign up in order to add this asset to your watchlist. Share Trillium Therapeutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free TR Stock Alerts